These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36524482)

  • 21. Nausea and vomiting in pregnancy: a review of the pathology and compounding opportunities.
    Zur E
    Int J Pharm Compd; 2013; 17(2):113-23. PubMed ID: 23696171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6).
    Bishai R; Mazzotta P; Atanackovic G; Levichek Z; Pole M; Magee LA; Koren G
    Can J Clin Pharmacol; 2000; 7(3):138-43. PubMed ID: 11044759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial.
    Koren G; Clark S; Hankins GD; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2010 Dec; 203(6):571.e1-7. PubMed ID: 20843504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of higher than standard dose of doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy.
    Atanackovic G; Navioz Y; Moretti ME; Koren G
    J Clin Pharmacol; 2001 Aug; 41(8):842-5. PubMed ID: 11504271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA approval of doxylamine-pyridoxine therapy for use in pregnancy.
    Slaughter SR; Hearns-Stokes R; van der Vlugt T; Joffe HV
    N Engl J Med; 2014 Mar; 370(12):1081-3. PubMed ID: 24645939
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy.
    Ashkenazi-Hoffnung L; Merlob P; Stahl B; Klinger G
    Isr Med Assoc J; 2013 Jan; 15(1):23-6. PubMed ID: 23484234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxylamine/pyridoxine for nausea and vomiting in pregnancy.
    Drug Ther Bull; 2019 Mar; 57(3):38-41. PubMed ID: 30705026
    [No Abstract]   [Full Text] [Related]  

  • 29. Simultaneous determination of pyridoxine hydrochloride and doxylamine succinate from tablets by ion pair reversed-phase high-performance liquid chromatography (RP-HPLC).
    Argekar AP; Sawant JG
    Drug Dev Ind Pharm; 1999 Aug; 25(8):945-50. PubMed ID: 10434138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of doxylamine-pyridoxine for morning sickness.
    Koren G; Hankins GD; Clark S; Caritis SN; Miodovnik M; Umans JG; Mattison DR
    Am J Obstet Gynecol; 2016 May; 214(5):664-6. PubMed ID: 26844757
    [No Abstract]   [Full Text] [Related]  

  • 31. Fatal overdose from Bendectin.
    Bayley M; Walsh FM; Valaske MJ
    Clin Pediatr (Phila); 1975 May; 14(5):507-9, 514. PubMed ID: 1126102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous determination of a ternary mixture of doxylamine succinate, pyridoxine hydrochloride, and folic acid by the ratio spectra-zero-crossing, double divisor-ratio spectra derivative, and column high-performance liquid chromatographic methods.
    Pathak A; Rajput SJ
    J AOAC Int; 2008; 91(5):1059-69. PubMed ID: 18980119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial.
    Oliveira LG; Capp SM; You WB; Riffenburgh RH; Carstairs SD
    Obstet Gynecol; 2014 Oct; 124(4):735-742. PubMed ID: 25198265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained-release dosage forms of microencapsulated isoniazid.
    Jalsenjak I; Nixon JR; Senjkovic R; Stivic I
    J Pharm Pharmacol; 1980 Oct; 32(10):678-80. PubMed ID: 6107339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing.
    Boskovic R; Einarson A; Maltepe C; Wolpin J; Koren G
    J Obstet Gynaecol Can; 2003 Oct; 25(10):830-3. PubMed ID: 14532951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghost-Pill-Buster: A Case Study of Intact Levetiracetam Extended-Release Tablets after Dissolution Testing.
    Sun D; Wen H; Externbrink A; Gao Z; Keire D; Krauss G; Jiang W
    CNS Drugs; 2016 May; 30(5):455-60. PubMed ID: 27048352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information.
    Zhang R; Persaud N
    PLoS One; 2017; 12(1):e0167609. PubMed ID: 28052111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
    Kulinowski P; Dorozyński P; Jachowicz R; Weglarz WP
    J Pharm Biomed Anal; 2008 Nov; 48(3):685-93. PubMed ID: 18715732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
    Koch HP; Alcorn G; Ritschel WA
    Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative evaluation using in vitro dissolution tests of various sustained release theophylline preparations].
    Kissné CE
    Acta Pharm Hung; 1990 Nov; 60(5-6):191-6. PubMed ID: 2087990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.